Symposia: Aggressive Lymphomas: Prospective Therapeutic Trials
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, Lymphomas, non-Hodgkin lymphoma, Bispecific Antibody Therapy, Non-Biological therapies, Clinical Research, B Cell lymphoma, Chemotherapy, Checkpoint Inhibitor, drug development, Diseases, aggressive lymphoma, Therapies, therapy sequence, Lymphoid Malignancies
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, Lymphomas, non-Hodgkin lymphoma, Bispecific Antibody Therapy, Non-Biological therapies, Clinical Research, B Cell lymphoma, Chemotherapy, Checkpoint Inhibitor, drug development, Diseases, aggressive lymphoma, Therapies, therapy sequence, Lymphoid Malignancies
Sunday, December 10, 2023: 9:30 AM-11:00 AM
Seaport Ballroom ABCD
(Manchester Grand Hyatt San Diego)
Moderators:
Eliza A Hawkes, MD, Austin Health
and
Reem Karmali, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center
Disclosures:
No relevant conflicts of interest to declare.
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH